Latest Gamma-Aminobutyric acid Stories
CORAL GABLES, Fla., April 9, 2010 /PRNewswire-FirstCall/ -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq: CPRX) today announced that on Friday April 16th, Eugene C.
CORAL GABLES, Fla., April 1 /PRNewswire-FirstCall/ -- Catalyst Pharmaceutical Partners, Inc.
UCSF scientists report that they were able to prompt a new period of â€œplasticity,â€ or capacity for change, in the neural circuitry of the visual cortex of juvenile mice.
The next advance in treating major depression may relate to a group of brain chemicals that are involved in virtually all our brain activity.
CORAL GABLES, Fla., Feb. 22 /PRNewswire-FirstCall/ -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq: CPRX) will hold a conference call on Tuesday, February 23, 2010 to discuss its initial development plans for CPP-115. Patrick J.
CORAL GABLES, Fla., Feb. 17 /PRNewswire/ -- Catalyst Pharmaceutical Partners, Inc.
Scientists have created what appears to be a schizophrenic mouse by reducing the inhibition of brain cells involved in complex reasoning and decisions about appropriate social behavior.
The research group of Professor Magdalena GÃ¶tz of Helmholtz Zentrum MÃ¼nchen and Ludwig-Maximilians-UniversitÃ¤t (LMU) Munich has made a significant advance in understanding regeneration processes in the brain.
NEW YORK, Oct.
There are increasingly precise molecular insights into ways that stress exposure leads to fear and through which fear extinction resolves these fear states.